You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

mCRPC; abiraterone; metformin

Showing 1 - 25 of 2,743
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Tumors Trial (MK-5684, Dexamethasone, Fludrocortisone

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer (mCRPC)
  • Prostatic Neoplasms
  • (no location specified)
Nov 21, 2023

Prostate Cancer Metastatic Trial (MK-5684, Abiraterone acetate, Enzalutamide)

Not yet recruiting
  • Prostate Cancer Metastatic
  • (no location specified)
Nov 21, 2023

Medicines Called Enzalutamide and Abiraterone in People With

Not yet recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • New York, New York
    Pfizer Inc
Jul 21, 2023

Prostate Cancer, Castrate Resistant Prostate Cancer Trial (Enzalutamide 40 MG, Docetaxel injection)

Not yet recruiting
  • Prostate Cancer
  • Castrate Resistant Prostate Cancer
  • Enzalutamide 40 MG
  • Docetaxel injection
  • (no location specified)
Jan 27, 2023

Metastatic Prostate Cancer Trial in Guangzhou (Metformin)

Not yet recruiting
  • Metastatic Prostate Cancer
  • Guangzhou, Guangdong, China
    Sun Yat-Sen University Cancer Center
Jun 11, 2021

Prostatic Tumors Trial in Worldwide (EPI-7386, Abiraterone Acetate, Prednisone or Prednisolone)

Suspended
  • Prostatic Neoplasms
  • Towson, Maryland
  • +3 more
Nov 3, 2022

Prostate Cancer Trial in Atlanta, Charleston (Opaganib, Abiraterone, Enzalutamide)

Recruiting
  • Prostate Cancer
  • Atlanta, Georgia
  • +1 more
Dec 28, 2022

Prostate Cancer Castration-resistant Prostate Cancer Trial in Changsha (Abiraterone+SHR3162)

Active, not recruiting
  • Prostate Cancer Castration-resistant Prostate Cancer
  • Changsha, Hunan, China
    Hunan Cancer Hospital
Jul 6, 2022

Metastatic Castration-resistant Prostate Cancer Trial in United Kingdom, United States (PLX2853, Olaparib, Abiraterone acetate)

Terminated
  • Metastatic Castration-resistant Prostate Cancer
  • Chicago, Illinois
  • +7 more
Oct 4, 2022

Next Generation PET and Liquid Biopsy to Monitor mCRPC Treated

Recruiting
  • Prostate Cancer
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Dec 27, 2021

Metastatic Castration-resistant Prostate Cancer (mCRPC) Trial in Shanghai (Abiraterone Acetate Tablets (I), ZYTIGA®)

Completed
  • Metastatic Castration-resistant Prostate Cancer (mCRPC)
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Feb 16, 2022

Prostatic Tumors, Castration-Resistant Trial in Leiden (Patient-specific adaptive therapy, Abiraterone acetate, Enzalutamide)

Recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • Patient-specific adaptive therapy
  • +2 more
  • Camperdown, New South Wales, Australia
  • +6 more
Jan 11, 2023

Prostate Cancer Metastatic Trial in Worldwide (ARV-110 in Combination with Abiraterone)

Recruiting
  • Prostate Cancer Metastatic
  • ARV-110 in Combination with Abiraterone
  • Santa Monica, California
  • +16 more
Jul 21, 2022

Prostate Cancer Metastatic Trial in Omaha, New York (Apalutamide, Abiraterone acetate, Docetaxel)

Active, not recruiting
  • Prostate Cancer Metastatic
  • Omaha, Nebraska
  • +1 more
Aug 26, 2021

Metastatic Castration-resistent Prostate Cancer Trial in Napoli (Docetaxel, Abiraterone Acetate or Enzalutamide)

Active, not recruiting
  • Metastatic Castration-resistent Prostate Cancer
  • Napoli, Italy
    Istituto Nazionale dei Tumori , Oncologia Medica - Dipartimento
Jul 27, 2021

Prostatic Tumors Trial in New York (CC-90011, Abiraterone, Prednisone)

Recruiting
  • Prostatic Neoplasms
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jul 21, 2022

Metastatic Castration-resistant Prostate Cancer Trial in New Orleans (Avelumab, 2nd generation ADT (abiraterone or

Terminated
Has Results
  • Metastatic Castration-resistant Prostate Cancer
  • Avelumab
  • 2nd generation ADT (abiraterone or enzalutamide)
  • New Orleans, Louisiana
    Tulane University School of Medicine
Apr 6, 2022

Prostate Cancer, Metastatic Castrate-Resistant Prostate Cancer, PSA Trial in Canada, United States (OGX-427, Abiraterone

Terminated
Has Results
  • Prostate Cancer
  • +2 more
  • Marina Del Rey, California
  • +15 more
Jul 7, 2022

mCRPC Trial in Shanghai (HC-1119, )

Recruiting
  • mCRPC
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 26, 2021

Prostatic Tumors Trial in Worldwide (Apalutamide, Abiraterone acetate, Prednisone)

Active, not recruiting
Has Results
  • Prostatic Neoplasms
  • Phoenix, Arizona
  • +183 more
Jan 17, 2023

Prostate Cancer Trial in Kogarah, Liverpool, Bedford Park (PCUR-101, Dutasteride 0.5 mg, Abiraterone and Prednisone)

Recruiting
  • Prostate Cancer
  • Ann Arbor, Michigan
  • +4 more
Jan 6, 2023

Metastatic Prostate Cancer in Pirkanmaa Hospital District in

Not yet recruiting
  • Metastatic Castration Sensitive Prostate Cancer (mCSPC)
  • Metastatic Castration Resistant Prostate Cancer (mCRPC)
  • (no location specified)
Jan 17, 2023

Metastatic Prostate Cancer Trial in Guangzhou (Metformin)

Not yet recruiting
  • Metastatic Prostate Cancer
  • Guangzhou, Guangdong, China
    Sun Yat-Sen University Cancer Center
Jun 8, 2021

Prostate Cancer Trial in United States (ARN-509, Abiraterone Acetate, Prednisone)

Active, not recruiting
  • Prostate Cancer
  • New Orleans, Louisiana
  • +13 more
Feb 5, 2022

Metastatic Castration-resistant Prostate Cancer Trial in Worldwide (Acapatamab, Enzalutamide, Abiraterone)

Active, not recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Birmingham, Alabama
  • +13 more
Jun 20, 2022